Position in NVS
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$82,278
+$2,085 QoQ
Shares Held
525
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#1,392
of 1,603 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Parvin Asset Management, LLC holds $5,571,752 across 10 Drug Manufacturers - General names. NVS ranks #7 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
5,619 | $2,034,752 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
19,245 | $1,108,896 | |
| 3 | ABBV |
AbbVie Inc.
|
3,625 | $912,195 | |
| 4 | JNJ |
Johnson & Johnson
|
3,470 | $881,275 | |
| 5 | MRK |
Merck & Co., Inc.
|
2,875 | $369,437 | |
| 6 | NVO |
Novo Nordisk A S
|
2,015 | $96,599 | |
| 7 | NVS |
Novartis AG
This page
|
525 | $82,278 | |
| 8 | PFE |
Pfizer Inc
|
2,100 | $50,568 |
All Filings in NVS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $82,278 | 525 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $80,193 | 525 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $72,381 | 525 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $67,326 | 525 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $63,530 | 525 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $58,527 | 525 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $51,087 | 525 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||